无效红细胞生成
医学
GDF15型
地中海贫血
内分泌学
β地中海贫血
红细胞生成
贫血
平衡
输血
铁蛋白
血红蛋白
缺铁
海西定
内科学
溶血性贫血
红细胞
血红蛋白病
红细胞
螯合疗法
促红细胞生成素
作者
Zeynep Ozturk,Saadet Gumuslu,Koray Yalcin,Alphan Kupesiz
出处
期刊:Journal of Pediatric Hematology Oncology
[Ovid Technologies (Wolters Kluwer)]
日期:2020-12-22
卷期号:43 (5): 186-192
被引量:3
标识
DOI:10.1097/mph.0000000000002046
摘要
Introduction: To clarify mechanisms of ineffective erythropoiesis on iron metabolism, studies on erythroid factors that regulating hepcidin suppression have been carried out. The aim of the current study is to identify associations between erythropoiesis and iron homeostasis parameters in β-thalassemias. Materials and Methods: This study consisted of 83 subjects: 21 thalassemia major (TM), 20 thalassemia intermedia (TI), 20 thalassemia trait (TT), and 22 healthy subjects (HS). Erythroferrone (ERFE), hepcidin, growth differentiation factor-15 (GDF15), erythropoietin (EPO), and iron status parameters were measured. Results: Our results showed that TM and TI patients had higher hepcidin than the TT and control groups. The hepcidin/ferritin in TM patients was significantly lower than the other groups. GDF15 in TM and TI patients was significantly higher than in the TT and control groups. Also, TI group had significantly higher ERFE concentration and EPO activity when compared with the TM, TT, and HS groups. EPO activity showed positive correlation with ERFE and GDF15 concentrations. We could not find any correlation between ERFE and hepcidin concentrations. Conclusions: ERFE may be one of the parameters used to demonstrate erythropoietic activity level in thalassemias. More detailed studies are needed to clarify the role of ERFE in iron metabolism in the patients with thalassemias.
科研通智能强力驱动
Strongly Powered by AbleSci AI